Este debate tiene 0 respuestas, 1 mensaje y ha sido actualizado por última vez el hace 3 años por César A. Coria Mercado.

  • Autor
  • #9016

    In the last LAC Platform Newsletter, we did publish a GFO note about: Advocates’ network report underscores critical need for Global Fund to ‘get back on track’ to end epidemics. The note indicate that:

    «Citing concerning epidemiological trends (slowing or too-small reductions in infections and deaths from AIDS, TB, and malaria) and data showing that even current levels of international assistance for the three diseases will be insufficient to reach global targets, the report calls for the global community to “get back on track.” For GFAN, getting back on track means substantially increasing the contributions of donor (and implementer) countries for disease control efforts, much of which could be done through expanded pledges to the Global Fund in next year’s replenishment drive. The centerpiece of the report is a bold, yet well-documented, statement of need for global financing for the three diseases over the 2020-2022 period, which will be funded through the Sixth Replenishment (see image below). For the Global Fund in particular, the report argues that donors need to increase pledges by at least 22% over the prior replenishment, which was launched in Montreal in September 2016, and covered the 2017-2019 period»

    Read the full note here and share:

    What national and / or local effects would have a reduction of international funding in your country for responses to HIV, TB and / or Malaria?

    And share. What actions can do community and civil society organizations in your country to support the actions of the GFAN?

Viendo 1 entrada (de un total de 1)

Debes estar registrado para responder a este debate.


¿Quieres saber más sobre la Comunidad de Plataforma LAC? Escríbenos y nos pondremos en contacto contigo tan pronto sea posible. Gracias.


2021 - LAC Platform | Except where otherwise mentioned, all the contents of the LAC Platform Community are under license CC BY-SA 4.0


Inicia Sesión con tu Usuario y Contraseña

¿Olvidó sus datos?